サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1538491

イースト菌感染症治療市場レポート：2030年までの動向、予測、競合分析

Yeast Infection Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

イースト菌感染症治療市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年07月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

イースト菌感染症治療の動向と予測

世界のイースト菌感染症治療市場は、2024年から2030年までのCAGRが4.6％で、2030年までに推定79億米ドルに達すると予測されます。この市場の主な促進要因は、自己免疫疾患およびイースト菌感染症の増加、感染症およびアレルギー疾患の発生率の大幅な上昇、イースト菌感染症の革新的治療に対する政府からの資金提供の増加です。世界のイースト菌感染症治療市場の将来は、小売薬局/ドラッグストア、病院薬局、専門店、オンライン販売市場に機会があり、有望視されています。

セグメント別イースト菌感染症治療

この調査には、治療タイプ別、適応症別、剤形別、流通チャネル別、地域別の世界のイースト菌感染症治療薬の予測が含まれています。

イースト菌感染症治療市場の洞察

Lucintelでは、錠剤/カプセルは様々なサイズがあり、保存期間が長いため、予測期間中も最大のセグメントであり続けると予測しています。

この市場の中では、小売薬局/ドラッグストアが最大のセグメントであり続けると思われます。

北米では膣感染症やイースト菌感染症の頻度が増加しているため、予測期間中も最大の地域であり続けるでしょう。

よくある質問

Q1.市場規模は：

A1.世界のイースト菌感染症治療市場は、2030年までに推定79億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界のイースト菌感染症治療市場は、2024年から2030年にかけてCAGR 4.6%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、自己免疫疾患やイースト菌感染症の増加、感染症やアレルギー疾患の発生率の大幅な上昇、イースト菌感染症の革新的治療に対する政府からの資金提供の増加です。

Q4.市場の主要セグメントは：

A4.世界のイースト菌感染症治療市場の将来は、小売薬局/ドラッグストア、病院薬局、専門店、オンライン販売市場での機会が有望です。

Q5.市場の主要企業は：

A5.主要なイースト菌感染症治療企業は以下の通りです：

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、錠剤/カプセルは様々なサイズがあり、保存期間が長いため、予測期間中も最大セグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、同地域における膣感染症およびイースト菌感染症の頻度が増加しているため、予測期間中も最大地域であり続けます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のイースト菌感染症治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のイースト菌感染症治療市場の動向（2018～2023年）と予測（2024～2030年）
  • 治療タイプ別世界のイースト菌感染症治療市場
    • アゾール
    • ポリジーン
    • エキノキャンディン
    • その他
  • 適応症別世界のイースト菌感染症治療市場
    • 性器カンジダ症
    • 侵襲性カンジダ症
    • 口腔咽頭/食道カンジダ症
    • その他
  • 剤形別世界のイースト菌感染症治療市場
    • 粉末
    • クリーム/軟膏
    • 錠剤/カプセル
    • その他
  • 流通チャネル別世界のイースト菌感染症治療市場
    • 小売薬局/ドラッグストア
    • 病院薬局
    • 専門店
    • オンライン販売
    • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

  • 地域別世界のイースト菌感染症治療市場
  • 北米のイースト菌感染症治療市場
  • 欧州のイースト菌感染症治療市場
  • アジア太平洋イースト菌感染症治療市場
  • その他地域イースト菌感染症治療市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 業務統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 治療タイプ別の世界のイースト菌感染症治療市場の成長機会
    • 適応症別の世界のイースト菌感染症治療市場の成長機会
    • 剤形別の世界のイースト菌感染症治療市場の成長機会
    • 流通チャネル別世界のイースト菌感染症治療市場の成長機会
    • 地域別の世界のイースト菌感染症治療市場の成長機会
  • 世界のイースト菌感染症治療市場における新たな動向
  • 戦略分析
    • 新製品開発
    • 世界のイースト菌感染症治療市場の能力拡大
    • 世界のイースト菌感染症治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer
目次

Yeast Infection Treatment Trends and Forecast

The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets. The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Yeast Infection Treatment by Segment

The study includes a forecast for the global yeast infection treatment by treatment type, indication, form, distribution channel, and region.

Yeast Infection Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Azoles
  • Polygene
  • Echinocandin
  • Others

Yeast Infection Treatment Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Genital Candidiasis
  • Invasive Candidiasis
  • Oropharyngeal/Esophageal Candidiasis
  • Others

Yeast Infection Treatment Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Powders
  • Creams/Ointments
  • Tablets/Capsules
  • Others

Yeast Infection Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacies/Drug Stores
  • Hospital Pharmacies
  • Specialty Stores
  • Online Sales
  • Others

Yeast Infection Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Yeast Infection Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies yeast infection treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the yeast infection treatment companies profiled in this report include-

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Yeast Infection Treatment Market Insights

Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Within this market, retail pharmacy/drug store will remain the largest segment.

North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Features of the Global Yeast Infection Treatment Market

Market Size Estimates: Yeast infection treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Yeast infection treatment market size by treatment type, indication, form, distribution channel, and region in terms of value ($B).

Regional Analysis: Yeast infection treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment type, indication, form, distribution channel, and regions for the yeast infection treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the yeast infection treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the yeast infection treatment market size?

Answer: The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030.

Q2. What is the growth forecast for yeast infection treatment market?

Answer: The global yeast infection treatment market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the yeast infection treatment market?

Answer: The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

Q4. What are the major segments for yeast infection treatment market?

Answer: The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets.

Q5. Who are the key yeast infection treatment market companies?

Answer: Some of the key yeast infection treatment companies are as follows:

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Q6. Which yeast infection treatment market segment will be the largest in future?

Answer: Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Q7. In yeast infection treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the yeast infection treatment market by treatment type (azoles, polygene, echinocandin, and others), indication (genital candidiasis, invasive candidiasis, oropharyngeal/esophageal candidiasis, and others), form (powders, creams/ointments, tablets/capsules, and others), distribution channel (retail pharmacies/drug stores, hospital pharmacies, specialty stores, online sales, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Yeast Infection Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Yeast Infection Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Yeast Infection Treatment Market by Treatment Type
    • 3.3.1: Azoles
    • 3.3.2: Polygene
    • 3.3.3: Echinocandin
    • 3.3.4: Others
  • 3.4: Global Yeast Infection Treatment Market by Indication
    • 3.4.1: Genital Candidiasis
    • 3.4.2: Invasive Candidiasis
    • 3.4.3: Oropharyngeal/Esophageal Candidiasis
    • 3.4.4: Others
  • 3.5: Global Yeast Infection Treatment Market by Form
    • 3.5.1: Powders
    • 3.5.2: Creams/Ointments
    • 3.5.3: Tablets/Capsules
    • 3.5.4: Others
  • 3.6: Global Yeast Infection Treatment Market by Distribution Channel
    • 3.6.1: Retail Pharmacies/Drug Stores
    • 3.6.2: Hospital Pharmacies
    • 3.6.3: Specialty Stores
    • 3.6.4: Online Sales
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Yeast Infection Treatment Market by Region
  • 4.2: North American Yeast Infection Treatment Market
    • 4.2.1: North American Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.2.2: North American Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.3: European Yeast Infection Treatment Market
    • 4.3.1: European Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.3.2: European Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.4: APAC Yeast Infection Treatment Market
    • 4.4.1: APAC Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.4.2: APAC Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.5: ROW Yeast Infection Treatment Market
    • 4.5.1: ROW Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.5.2: ROW Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Yeast Infection Treatment Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Yeast Infection Treatment Market by Indication
    • 6.1.3: Growth Opportunities for the Global Yeast Infection Treatment Market by Form
    • 6.1.4: Growth Opportunities for the Global Yeast Infection Treatment Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Yeast Infection Treatment Market by Region
  • 6.2: Emerging Trends in the Global Yeast Infection Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Yeast Infection Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Yeast Infection Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Astellas Pharma
  • 7.2: Astra Zeneca
  • 7.3: Abbott Laboratories
  • 7.4: Allergan
  • 7.5: Brundavan Laboratories
  • 7.6: Bayer
  • 7.7: Corden Pharma
  • 7.8: Merck & Co
  • 7.9: Novartis
  • 7.10: Pfizer